Giant Biogene Holding Co., Ltd. (02367.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.9x

Market Cap

HKD 28.51B

MomentumView details →

1D Return

+3.50%

YTD Return

−20.01%

RSI (14)

43.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

3.9x

Market Cap

HKD 28.51B

RSI (14)

43.3

MomentumView details →

1D Return

+3.50%

YTD Return

−20.01%

ProfitabilityView details →

Gross Margin

80.51%

Net Margin

34.41%

EBITDA Margin

38.25%

ROE (TTM)

41.90%

ROA (TTM)

38.28%

Asset Turnover

1.08x

GrowthView details →

Revenue YoY

+53.06%

EPS YoY

+27.42%

FCF YoY

−7.53%

Revenue CAGR 3Y

+32.65%

EPS CAGR 3Y

+22.73%

EBITDA YoY

+26.29%

EarningsView details →

EPS (Actual)

HKD 1.03

EPS Surprise

0.98%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

0.98%

Rev Surprise

0.73%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.63x

Quick Ratio

10.18x

Div Yield

5.22%

Div Rate

HKD 1.39

Div Growth 1Y

+6.39%

Financials snapshotView financials →

Revenue (TTM)

11.39B

Net Income (TTM)

3.92B

Op. CF (TTM)

3.00B

Next earningsMar 29, 2027 →

Latest newsMore news →

Giant Biogene Holding Co., Ltd reported a drop in first-half profit for the period ended June 2026, with net income falling to RMB939.71 million from RMB1.182 billion a year earlier.17d ago

Similar companies

Daelim Trading Co., Ltd.006570.KS Mao Geping Cosmetics Co., Ltd.01318.HK Hengan International Group Company Limited01044.HK Church & Dwight Co., Inc.CHD Kimberly-Clark CorporationKMB Kenvue Inc.KVUE Find similar companies →

Latest newsMore news →

Giant Biogene Holding Co., Ltd reported a drop in first-half profit for the period ended June 2026, with net income falling to RMB939.71 million from RMB1.182 billion a year earlier.17d ago